| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | WRBY Warby Parker Inc. | Miller Steven Clive62 | Chief Financial Officer | Sell | 11,684 | $23.52 | $274,807.68 | -5.4% | -7.5% | +17.8% | |
| Mar 4, 2025 | CERS Cerus Corp | Jensen Chrystal71 | Chief Legal Officer | Sell | 66,292 | $1.58 | $104,885.16 | -7.1% | -16.5% | +41.1% | |
| Mar 4, 2025 | CERS Cerus Corp | Greenman William Mariner70 | President And CEO | Sell | 23,023 | $1.55 | $35,651.12 | -0.7% | -16.5% | +41.1% | |
| Mar 3, 2025 | PEN Penumbra Inc | O'Rourke Bridget56 | Director | Sell | 50 | $285.48 | $14,274.00 | -0.9% | -10.4% | +19.0% | |
| Mar 3, 2025 | NXGL Nexgel, Inc. | Levy Adam R.77 | Chief Executive Officer | Sell | 4,000 | $3.16 | $12,638.80 | -1.1% | -23.2% | -61.9% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Wilson Daniel G.62 | Chief Financial Officer | Sell | 2,341 | $108.77 | $254,630.57 | -4.9% | +28.9% | +15.4% | |
| Mar 3, 2025 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 22,355 | $7.65 | $170,920.96 | -2.3% | -62.2% | -81.6% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | Sell | 314 | $108.77 | $34,153.78 | -2.7% | +28.9% | +15.4% | |
| Mar 3, 2025 | RMD Resmed Inc | Ghoshal Kaushik64 | Chief Commercial Officer, Saas | Sell | 9,113 | $235.40 | $2,145,185.96 | -13.7% | +4.7% | +10.8% | |
| Mar 3, 2025 | AXGN Axogen, Inc. | Wendell Amy McBride46 | Director | Sell | 5,000 | $20.02 | $100,100.00 | -4.9% | -43.1% | +54.5% | |
| Mar 3, 2025 | NVCR Novocure Ltd | Paravasthu Mukund69 | Chief Operating Officer | Sell | 250 | $18.54 | $4,634.08 | -0.8% | -7.4% | -27.8% | |
| Mar 3, 2025 | PEN Penumbra Inc | Yuen Maggie49 | Chief Financial Officer | Sell | 2,000 | $286.00 | $571,994.90 | -2.4% | -10.4% | +19.0% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Blackford Quentin S.60 | President And CEO | Sell | 8,145 | $108.77 | $885,931.65 | -3.8% | +28.9% | +15.4% | |
| Mar 3, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 324 | $25.46 | $8,249.04 | -0.2% | -15.6% | -17.7% | |
| Mar 3, 2025 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 2,407 | $76.43 | $183,967.01 | -6.3% | +78.8% | +113.5% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Murphy Patrick Michael55 | Cbo And CLO | Sell | 3,075 | $108.77 | $334,467.75 | -5.2% | +28.9% | +15.4% | |
| Mar 3, 2025 | ABT Abbott Laboratories | Shroff Eric | Senior Vice President | Sell | 562 | $138.17 | $77,651.54 | -1.7% | -4.7% | -19.0% | |
| Mar 3, 2025 | IRTC Irhythm Holdings, Inc. | Smith Mervin | EVP Strategic Business Ops | Sell | 638 | $108.77 | $69,395.26 | -3.7% | +28.9% | +15.4% | |
| Mar 3, 2025 | RMD Resmed Inc | Rider Michael J49 | Global General Counsel | Sell | 64 | $234.10 | $14,982.40 | -0.7% | +4.7% | +10.8% | |
| Mar 3, 2025 | INSP Inspire Medical Systems, Inc. | Ban Randy68 | See Remarks | Sell | 3,947 | $185.84 | $733,495.72 | -14.1% | -26.7% | -63.9% | |
| Mar 3, 2025 | ATEC Alphatec Holdings, Inc. | McGinnis Karen K | Director | Sell | 38,320 | $12.26 | $469,803.20 | -40.0% | +0.2% | +6.1% | |
| Mar 3, 2025 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $287.43 | $172,458.48 | - | -10.4% | +19.0% | |
| Mar 3, 2025 | MMSI Merit Medical Systems Inc | Evans Stephen C.62 | Director | Sell | 5,000 | $105.31 | $526,550.00 | -51.8% | -9.1% | -27.4% | |
| Mar 3, 2025 | PACB Pacific Biosciences Of California, Inc. | Farmer Michele68 | See Remarks | Sell | 2,973 | $1.41 | $4,183.01 | -1.6% | -24.9% | +16.0% | |
| Mar 3, 2025 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 660 | $25.46 | $16,803.60 | -0.5% | -15.6% | -17.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.